Fostering shared decision-making about prostate cancer screening among African American men patients and their primary care providers: a randomized behavioral clinical trial

Table 2 Quantitative patient measures

Quantitative patient measures^a	Enrollment (visit 1)	Intervention	Medical encounter (visit 2)	Follow-up (visit 3)
Timepoint	(− 7 to − 60 days before visit 2)	(After enrollment and before visit 2)	(appt. day)	(90–105 days after visit 2)
Approximate time to complete	15 to 30 min	30 to 45 min	60 min	15 to 20 min
Enrollment:
Eligibility screening	X
Invitation to join study	X
Informed consent	X
HIPAA authorization	X
Baseline	X
Allocation (randomization)	X
Intervention
Decision-aid (training)		X
Assessments
Baseline
Demographics	X
Health literacy	X
Primary outcomes
OPTION Scale [10]			X
Shared Decision Making-patient version [11]			X
Secondary outcomes
Prostate Cancer Knowledge [13]	X	X		X
Decisional Confidence [14]	X			X
Satisfaction with Decision [15]	X			X
Decisional Self-efficacy [16]	X		X
Intention-to-screen [17]	X	X	X	X
PSA screening test orders^b	X		X	X
Actual receipt of PSA test^b	X		X	X
Tertiary outcomes
Acceptability and application of intervention (decision-aid)		X
Acceptability of study procedures, patient version [18]				X

^aMeasures used in this study have been adapted from the ones found in the literature
^bData extracted from the electronic medical record

ISSN: 1745-6215